Bain Capital Life Sciences Investors, LLC
CIK 1703031 · Holdings on Sep 30, 2026 · First reported Nov 16, 2026
Top ten holdings
Q3 2026- KLRA17.31%
- HTFL14.85%
- ADRX9.01%
- ALKS8.57%
- NAMS6.21%
- SVRA6.10%
- TARS5.78%
- PHVS5.16%
- SLDB4.76%
- OLMA4.11%
Share classes counted separately81.86%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- KLRAWeight decreased · -12.27 pp29.58% → 17.31%Shares 0 (0.00%)
- ALKSWeight increased · +2.53 pp6.04% → 8.57%Shares +1.21M (+62.59%)
- NAMSWeight decreased · -1.46 pp7.67% → 6.21%Shares -7 (-0.00%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 23
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | KLRAKAILERA THERAPEUTICS INCCOMMON STOCK View history and evidence | $257.90M | 17.31% | 22.58M shares | 29.58% → 17.31%-12.27 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | HTFLHEARTFLOW INC View history and evidence | $221.30M | 14.85% | 4.45M shares | 14.74% → 14.85%+0.11 pp -4.00M (-47.35%) | Reduced | ↗▾ |
| 03 | ADRXADARX PHARMACEUTICALS INC View history and evidence | $134.18M | 9.01% | 6.73M shares | Prior unavailable +6.73M | New | ↗▾ |
| 04 | ALKSALKERMES PLCSHS View history and evidence | $127.68M | 8.57% | 3.15M shares | 6.04% → 8.57%+2.53 pp +1.21M (+62.59%) | Added | ↗▾ |
| 05 | NAMSNEWAMSTERDAM PHARMA CO NVORDINARY SHARES View history and evidence | $92.58M | 6.21% | 3.81M shares | 7.67% → 6.21%-1.46 pp -7 (-0.00%) | Reduced | ↗▾ |
| 06 | SVRASAVARA INC View history and evidence | $90.82M | 6.10% | 17.60M shares | 6.45% → 6.10%-0.35 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | TARSTARSUS PHARMACEUTICALS INC View history and evidence | $86.17M | 5.78% | 1.10M shares | Prior unavailable +1.10M | New | ↗▾ |
| 08 | PHVSPHARVARIS NV View history and evidence | $76.92M | 5.16% | 2.48M shares | 5.50% → 5.16%-0.34 pp -200.00K (-7.48%) | Reduced | ↗▾ |
| 09 | SLDBSOLID BIOSCIENCES INCCOM NEW View history and evidence | $70.92M | 4.76% | 9.81M shares | 5.83% → 4.76%-1.07 pp 0 (0.00%) | Unchanged | ↗▾ |
| 10 | OLMAOLEMA PHARMACEUTICALS INC View history and evidence | $61.22M | 4.11% | 7.09M shares | 5.27% → 4.11%-1.16 pp 0 (0.00%) | Unchanged | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 2
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| DNTH DIANTHUS THERAPEUTICS INC | Non-derivative | -362,470 | -$35.33M | SEC filing ↗ | SEC filing ↗ |
| UPB UPSTREAM BIO INC | Non-derivative | -600,949 | -$4.16M | SEC filing ↗ | SEC filing ↗ |
2 / 2 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1703031 · Period Sep 30, 2026
Data loaded Nov 17, 2026 · First reported Nov 16, 2026
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 1489841174
}Take these holdings further.
This page includes 23 of 23 reported holdings. Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
+ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 23 of 23 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_institutional_holdings
{"action":"portfolio","cik":"1703031","quarter":"2026Q3","page_size":100}
akkru_institutional_holdings
{"action":"history","cik":"1703031","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.